Tasso Launches Tasso Care® for Prescreening to Streamline At‑Home Clinical Trial Screening
Tasso launched Tasso Care® for Prescreening, a full-service, at-home blood collection and analysis platform that streamlines clinical trial prescreening to boost enrollment, diversity, and sample quality while expanding panels for multiple therapeutic areas.
Tasso announces CE Mark for Tasso+™ lancet, achieving EU market access and joining prior U.S. 510(k) clearance
Tasso announced CE Mark certification for its Tasso+™ virtually pain-free whole blood collection lancet, enabling sales across the EU and marking full clearance after prior FDA 510(k) Class II clearance; the device aims to expand decentralized clinical trials, home diagnostics, and remote testing access in Europe.
Organizations
-
Tasso Media Contact · current
